UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.174-179

2019

Volltextzugriff (PDF)

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer

Annals of oncology, 2021-09, Vol.32 (9), p.1137-1147

2021

Volltextzugriff (PDF)

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

Annals of oncology, 2015-07, Vol.26 (7), p.1421-1427

2015

Volltextzugriff (PDF)

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

European journal of cancer (1990), 2019-01, Vol.107, p.124-132

2019

Volltextzugriff (PDF)

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Annals of oncology, 2016-01, Vol.27 (1), p.185-192

2016

Volltextzugriff (PDF)

Risk factors of nivolumab-induced pneumonitis in patients with solid tumors

Annals of oncology, 2018-11, Vol.29, p.ix119-ix119

2018

Volltextzugriff (PDF)

A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290‐kDa antigens

Journal of the European Academy of Dermatology and Venereology, 2018-09, Vol.32 (9), p.e354-e355

2018

Volltextzugriff (PDF)

Spectroscopic performance improvement of SOI pixel detector for X-ray astronomy by introducing Double-SOI structure

Journal of instrumentation, 2020-11, Vol.15 (11), p.P11001-P11001

2020

Volltextzugriff (PDF)

A case of childhood‐onset cutaneous mastocytosis with loss of wild‐type KIT allele

Journal of the European Academy of Dermatology and Venereology, 2019-06, Vol.33 (6), p.e235-e237

2019

Volltextzugriff (PDF)

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer

ESMO open, 2022-08, Vol.7 (4), p.100527, Article 100527

2022

Volltextzugriff (PDF)

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma

Journal of the European Academy of Dermatology and Venereology, 2018-07, Vol.32 (7), p.e299-e301

2018

Volltextzugriff (PDF)

Comparative analysis of overall survival using propensity score between first- and second-generation EGFR-TKI: Real world data of 1354 patients with EGFR mutant NSCLC

Annals of oncology, 2018-10, Vol.29, p.viii526-viii527

2018

Volltextzugriff (PDF)

Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells

Oncogene, 2010-04, Vol.29 (13), p.1941-1951

2010

Volltextzugriff (PDF)

Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii741-viii742

2018

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib

International journal of dermatology, 2018-07, Vol.57 (7), p.e31-e33

2018

Volltextzugriff (PDF)

Real-world data of EGFR minor mutated NSCLC treated with EGFR-TKI: Comparative analysis including compound mutation and de novo T790M mutation

Annals of oncology, 2018-11, Vol.29, p.ix161-ix161

2018

Volltextzugriff (PDF)

Development of on-chip pattern processing in event-driven SOI pixel detector for X-ray astronomy with background rejection purpose

Journal of instrumentation, 2020-12, Vol.15 (12), p.P12025-P12025

2020

Volltextzugriff (PDF)

3068 Impact of total lesion glycolysis at pretreatment FDG PET/CT on response duration of EGFR-TKIs in advanced NSCLC harboring EGFR mutation

European journal of cancer (1990), 2015-09, Vol.51, p.S619-S619

2015

Volltextzugriff (PDF)

3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients

European journal of cancer (1990), 2015-09, Vol.51, p.S619-S619

2015

Volltextzugriff (PDF)

Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii748-viii748

2018

Volltextzugriff (PDF)

Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation

Annals of oncology, 2018-10, Vol.29, p.viii525-viii525

2018

Volltextzugriff (PDF)

Light compensation points in shade-grown seedlings of deciduous broadleaf tree species with different successional traits raised under elevated CO2

Plant biology (Stuttgart, Germany), 2016-01, Vol.18 (S1), p.22-27

2016

Volltextzugriff (PDF)

Sub-pixel response of double-SOI pixel sensors for X-ray astronomy

Journal of instrumentation, 2019-10, Vol.14 (10), p.C10023-C10023

2019

Volltextzugriff (PDF)

Time to first cigarette and lung cancer risk in Japan

Annals of oncology, 2013-11, Vol.24 (11), p.2870-2875

2013

Volltextzugriff (PDF)

Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung

European journal of cancer (1990), 2017-02, Vol.72, p.S178-S178

2017

Volltextzugriff (PDF)

1 – 25 von 7.994

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.177)
Mit Volltextzugriff
(6.191)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(3.474)
MEDLINE
(2.437)
IngentaConnect Journals
(2.344)
Journals@Ovid Complete
(1.558)
Single Journals
(1.168)
Elsevier ScienceDirect Journals Complete
(1.027)
IngentaConnect Journals
(850)
Wiley Online Library
(706)
Springer Journals
(663)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(615)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(449)
Wiley Online Library
(395)
Oxford University Press Journals Current
(309)
IEEE
(303)
Ebook Central Perpetual and DDA
(281)
Oxford Journals 2020 Medicine
(175)
eBooks on EBSCOhost
(169)
Nexis Uni
(162)
Nature
(145)
Taylor & Francis Journals
(135)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Risk factors of nivolumab-induced pneumonitis in patients with solid tumors

A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290‐kDa antigens

Spectroscopic performance improvement of SOI pixel detector for X-ray astronomy by introducing Double-SOI structure

A case of childhood‐onset cutaneous mastocytosis with loss of wild‐type KIT allele

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma

Comparative analysis of overall survival using propensity score between first- and second-generation EGFR-TKI: Real world data of 1354 patients with EGFR mutant NSCLC

Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells

Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib

Real-world data of EGFR minor mutated NSCLC treated with EGFR-TKI: Comparative analysis including compound mutation and de novo T790M mutation

Development of on-chip pattern processing in event-driven SOI pixel detector for X-ray astronomy with background rejection purpose

3068 Impact of total lesion glycolysis at pretreatment FDG PET/CT on response duration of EGFR-TKIs in advanced NSCLC harboring EGFR mutation

3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients

Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC)

Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation

Light compensation points in shade-grown seedlings of deciduous broadleaf tree species with different successional traits raised under elevated CO2

Sub-pixel response of double-SOI pixel sensors for X-ray astronomy

Time to first cigarette and lung cancer risk in Japan

Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung

Suchergebnisse filtern